Showing results (111-120 of 300) with videos related to

Sort By:
Pageof 30
Clinical Endocrinology|November 30, 2016
Is it time to reconsider lobectomy in low-risk paediatric thyroid cancer?Wouter P Kluijfhout, Jesse D Pasternak, Danielle van der Kaay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2015
Prevalence and functional consequence of TP53 mutations in pediatric adrenocortical carcinoma: a children's oncology group studyJonathan D Wasserman, Ana Novokmet, Claudia Eichler-Jonsson, et al.
European Journal of Endocrinology|July 27, 2019
Treatment and long-term outcomes in pituitary carcinoma: a cohort studyFernando Santos-Pinheiro, Marta Penas-Prado, Carlos Kamiya-Matsuoka, et al.
The Journal of Clinical Endocrinology and Metabolism|July 23, 2018
Targeted Therapy in Advanced Thyroid Cancer to Resensitize Tumors to Radioactive IodineTania Jaber, Steven G Waguespack, Maria E Cabanillas, et al.
Pediatric Blood & Cancer|September 13, 2018
"A change in perspective": Exploring the experiences of adolescents with hereditary tumor predispositionEvan Weber, Cheryl Shuman, Jonathan D Wasserman, et al.
The Journal of Clinical Investigation|September 15, 2021
Oncogene-specific inhibition in the treatment of advanced pediatric thyroid cancerAime T Franco, Julio C Ricarte-Filho, Theodore W Laetsch, et al.
World Journal of Surgery|May 9, 2006
Management of pancreatic endocrine tumors in multiple endocrine neoplasia type 1Maria A Kouvaraki, Suzanne E Shapiro, Gilbert J Cote, et al.
Thyroid : Official Journal of the American Thyroid Association|August 23, 2018
Immune-Related Thyroiditis with Immune Checkpoint InhibitorsPriyanka C Iyer, Maria E Cabanillas, Steven G Waguespack, et al.
Journal for Immunotherapy of Cancer|January 11, 2021
Efficacy of pembrolizumab in patients with pituitary carcinoma: report of four cases from a phase II studyNazanin Majd, Steven G Waguespack, Filip Janku, et al.
Thyroid : Official Journal of the American Thyroid Association|December 4, 2024
Efficacy and Safety of Selective RET Inhibitors in Patients with Advanced Hereditary Medullary Thyroid CarcinomaSarah Hamidi, Sireesha Yedururi, Mimi I Hu, et al.
Pageof 30